Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 397

1.

Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy.

Picillo M, Cuoco S, Amboni M, Bonifacio FP, Bruno A, Bruschi F, Cappiello A, De Micco R, De Rosa A, Di Biasio F, Elifani F, Erro R, Fabbri M, Falla M, Franco G, Frosini D, Galantucci S, Lazzeri G, Magistrelli L, Malaguti MC, Milner AV, Minafra B, Olivola E, Pilotto A, Rascunà C, Rizzetti MC, Schirinzi T, Borroni B, Ceravolo R, Di Fonzo A, Lopiano L, Marchese R, Mercuri NB, Modugno N, Nicoletti A, Padovani A, Santangelo G, Stefani A, Tessitore A, Volontè MA, Zangaglia R, Zappia M, Barone P.

Neurol Sci. 2019 Jun 12. doi: 10.1007/s10072-019-03944-x. [Epub ahead of print]

PMID:
31190253
2.

Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" Clinical Biochemistry 46 (2013) 918-925.

Vannini I, Fanini F, Fabbri M.

Clin Biochem. 2019 Jun;68:58. doi: 10.1016/j.clinbiochem.2019.05.004. Epub 2019 May 23. No abstract available.

PMID:
31128843
3.

Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?

Fabbri M, Zibetti M, Ferrero G, Accornero A, Guimaraes I, Rizzone MG, Romagnolo A, Ferreira JJ, Lopiano L.

Parkinsonism Relat Disord. 2019 Apr 28. pii: S1353-8020(19)30213-5. doi: 10.1016/j.parkreldis.2019.04.018. [Epub ahead of print]

PMID:
31060986
4.

Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease.

Fabbri M, Pongmala C, Artusi CA, Romagnolo A, Rizzone MG, Zibetti M, Lopiano L.

Acta Neurol Scand. 2019 Apr 26. doi: 10.1111/ane.13110. [Epub ahead of print]

PMID:
31025312
5.

Dysphagia predicts poor outcome in late-stage Parkinson's disease.

Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Godinho C, Cardoso R, Guimaraes I, Antonini A, Zibetti M, Lopiano L, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Mar 2. pii: S1353-8020(19)30089-6. doi: 10.1016/j.parkreldis.2019.02.043. [Epub ahead of print]

PMID:
30902528
6.

Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells.

Wu CH, Li J, Li L, Sun J, Fabbri M, Wayne AS, Seeger RC, Jong AY.

J Extracell Vesicles. 2019 Mar 12;8(1):1588538. doi: 10.1080/20013078.2019.1588538. eCollection 2019.

7.

Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond.

Fabbri M, Frixou M, Degano M, Fousteri G.

Diabetes. 2019 Feb;68(2):258-265. doi: 10.2337/db18-0627.

PMID:
30665954
8.

Dissecting diffuse large B-cell lymphomas of the "not otherwise specified" type: the impact of molecular techniques.

Pileri SA, Derenzini E, Melle F, Motta G, Calleri A, Antoniotti P, Maltoni V, Spagnolo S, Fiori S, Tabanelli V, Fabbri M.

F1000Res. 2018 Dec 21;7. pii: F1000 Faculty Rev-1966. doi: 10.12688/f1000research.16755.1. eCollection 2018. Review.

9.

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.

Gagno S, D'Andrea MR, Mansutti M, Zanusso C, Puglisi F, Dreussi E, Montico M, Biason P, Cecchin E, Iacono D, Russo S, Cinausero M, Saracchini S, Gasparini G, Sartori D, Bari M, Collovà E, Meo R, Merkabaoui G, Spagnoletti I, Pellegrino A, Gianni L, Sandri P, Cretella E, Vattemi E, Rocca A, Serra P, Fabbri MA, Benedetti G, Foghini L, Medici M, Basso U, Amoroso V, Riccardi F, Baldelli AM, Clerico M, Bonura S, Saggia C, Innocenti F, Toffoli G.

Clin Breast Cancer. 2019 Apr;19(2):137-145.e4. doi: 10.1016/j.clbc.2018.11.009. Epub 2018 Nov 24.

10.

Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" [Clinical Biochemistry 46 (2013) 918-925].

Vannini I, Fanini F, Fabbri M.

Clin Biochem. 2019 Jan;63:162. doi: 10.1016/j.clinbiochem.2018.11.014. Epub 2018 Dec 14. No abstract available.

PMID:
30559003
11.

Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.

Neviani P, Wise PM, Murtadha M, Liu CW, Wu CH, Jong AY, Seeger RC, Fabbri M.

Cancer Res. 2019 Mar 15;79(6):1151-1164. doi: 10.1158/0008-5472.CAN-18-0779. Epub 2018 Dec 12.

PMID:
30541743
12.

Face-from-Depth for Head Pose Estimation on Depth Images.

Borghi G, Fabbri M, Vezzani R, Calderara S, Cucchiara R.

IEEE Trans Pattern Anal Mach Intell. 2018 Dec 7. doi: 10.1109/TPAMI.2018.2885472. [Epub ahead of print]

PMID:
30530311
13.

Fossilization transforms vertebrate hard tissue proteins into N-heterocyclic polymers.

Wiemann J, Fabbri M, Yang TR, Stein K, Sander PM, Norell MA, Briggs DEG.

Nat Commun. 2018 Nov 9;9(1):4741. doi: 10.1038/s41467-018-07013-3.

14.

Anterior cruciate ligament reconstruction is associated with greater tibial tunnel widening when using a bioabsorbable screw compared to an all-inside technique with suspensory fixation.

Monaco E, Fabbri M, Redler A, Gaj E, De Carli A, Argento G, Saithna A, Ferretti A.

Knee Surg Sports Traumatol Arthrosc. 2018 Nov 7. doi: 10.1007/s00167-018-5275-x. [Epub ahead of print]

PMID:
30406408
15.

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.

Gamucci T, Pizzuti L, Natoli C, Mentuccia L, Sperduti I, Barba M, Sergi D, Iezzi L, Maugeri-Saccà M, Vaccaro A, Magnolfi E, Gelibter A, Barchiesi G, Magri V, D'Onofrio L, Cassano A, Rossi E, Botticelli A, Moscetti L, Omarini C, Fabbri MA, Scinto AF, Corsi D, Carbognin L, Mazzotta M, Bria E, Foglietta J, Samaritani R, Garufi C, Mariani L, Barni S, Mirabelli R, Sarmiento R, Graziano V, Santini D, Marchetti P, Tonini G, Di Lauro L, Sanguineti G, Paoletti G, Tomao S, De Maria R, Veltri E, Paris I, Giotta F, Latorre A, Giordano A, Ciliberto G, Vici P.

Cancer Biol Ther. 2018 Nov 7:1-9. doi: 10.1080/15384047.2018.1523095. [Epub ahead of print]

16.

Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.

Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L.

Eur J Neurol. 2019 Mar;26(3):490-496. doi: 10.1111/ene.13844. Epub 2018 Nov 18.

PMID:
30347489
17.

Isokinetic flexion strength recovery after ACL reconstruction: a comparison between all inside graft-link technique and full tibial tunnel technique.

Monaco E, Redler A, Fabbri M, Proietti L, Gaj E, Daggett M, Ferretti A.

Phys Sportsmed. 2019 Feb;47(1):132-135. doi: 10.1080/00913847.2018.1537535. Epub 2018 Nov 2.

PMID:
30347173
18.

Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach.

Fabbri M, Rosa MM, Ferreira JJ.

Drugs Aging. 2018 Dec;35(12):1041-1054. doi: 10.1007/s40266-018-0599-2. Review.

PMID:
30318555
19.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2018 Dec 1;29(12):2363-2370. doi: 10.1093/annonc/mdy450.

20.

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.

Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O.

Mov Disord. 2018 Oct;33(10):1528-1539. doi: 10.1002/mds.27475. Epub 2018 Sep 27. Review.

PMID:
30264443
21.

Theory of mind and joint action in Parkinson's disease.

Fabbri M, Vitale C, Cuoco S, Beracci A, Calabrese R, Cordella M, Mazzotta R, Barone P, Pellecchia MT, Santangelo G.

Cogn Affect Behav Neurosci. 2018 Dec;18(6):1320-1337. doi: 10.3758/s13415-018-0642-0.

PMID:
30259349
22.

The human RNASET2 protein affects the polarization pattern of human macrophages in vitro.

Scaldaferri D, Bosi A, Fabbri M, Pedrini E, Inforzato A, Valli R, Frattini A, De Vito A, Noonan DM, Taramelli R, Mortara L, Acquati F.

Immunol Lett. 2018 Nov;203:102-111. doi: 10.1016/j.imlet.2018.09.005. Epub 2018 Sep 12.

PMID:
30218741
23.

Lipid-protein interactions in mitochondrial membranes from bivalve mollusks: molecular strategies in different species.

Fiorini R, Ventrella V, Trombetti F, Fabbri M, Pagliarani A, Nesci S.

Comp Biochem Physiol B Biochem Mol Biol. 2019 Jan;227:12-20. doi: 10.1016/j.cbpb.2018.08.010. Epub 2018 Sep 7.

PMID:
30196154
24.

Epigenetics of gastrointestinal diseases: notes from a workshop.

Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico ME.

Epigenetics. 2018;13(4):449-457. doi: 10.1080/15592294.2018.1464351. Epub 2018 Jul 30.

25.

Lifestyle factors and risk for colorectal polyps and cancer at index colonoscopy in a FIT-positive screening population.

Colussi D, Fabbri M, Zagari RM, Montale A, Bazzoli F, Ricciardiello L.

United European Gastroenterol J. 2018 Jul;6(6):935-942. doi: 10.1177/2050640618764711. Epub 2018 Mar 8.

26.

Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis.

Zanotti S, Gibertini S, Blasevich F, Bragato C, Ruggieri A, Saredi S, Fabbri M, Bernasconi P, Maggi L, Mantegazza R, Mora M.

Matrix Biol. 2018 Dec;74:77-100. doi: 10.1016/j.matbio.2018.07.003. Epub 2018 Jul 5.

PMID:
29981373
27.

Beyond 35 years of Parkinson's disease: a comprehensive clinical and instrumental assessment.

Romagnolo A, Fabbri M, Merola A, Montanaro E, Palermo S, Martone T, Seresini A, Goldwurm S, Rizzone MG, Lopiano L.

J Neurol. 2018 Sep;265(9):1989-1997. doi: 10.1007/s00415-018-8955-z. Epub 2018 Jun 26.

PMID:
29943201
28.

Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma.

Derenzini E, Agostinelli C, Rossi A, Rossi M, Scellato F, Melle F, Motta G, Fabbri M, Diop F, Kodipad AA, Chiappella A, Vitolo U, Gaidano G, Tarella C, Pileri S.

Br J Haematol. 2019 Apr;185(2):330-334. doi: 10.1111/bjh.15442. Epub 2018 Jun 17. No abstract available.

PMID:
29911350
29.

Perceived Social Isolation and Outcomes in Patients With Heart Failure.

Manemann SM, Chamberlain AM, Roger VL, Griffin JM, Boyd CM, Cudjoe TKM, Jensen D, Weston SA, Fabbri M, Jiang R, Finney Rutten LJ.

J Am Heart Assoc. 2018 May 23;7(11). pii: e008069. doi: 10.1161/JAHA.117.008069.

30.

Relapsing Malaria: A Case Report of Primaquine Resistance.

Dijanic C, Nickerson J, Shakya S, Dijanic A, Fabbri M.

Case Rep Infect Dis. 2018 Mar 11;2018:9720823. doi: 10.1155/2018/9720823. eCollection 2018.

31.

European Society of Cardiology-Proposed Diagnostic Echocardiographic Algorithm in Elective Patients with Clinical Suspicion of Infective Endocarditis: Diagnostic Yield and Prognostic Implications in Clinical Practice.

Barbieri A, Mantovani F, Lugli R, Bursi F, Fabbri M, Bartolacelli Y, Manicardi M, Stefanelli G, Mussini C, Boriani G.

J Cardiovasc Echogr. 2018 Jan-Mar;28(1):26-31. doi: 10.4103/jcecho.jcecho_49_17.

32.

WITHDRAWN: Corrigendum to 'Development of an Italian RM Y-STR haplotype database: results of the 2013 GEFI collaborative exercise' [Forensic. Sci. Int. Genet. 15 (2015) 56-63].

Robino C, Ralf A, Pasino S, De Marchi MR, Ballantyne KN, Barbaro A, Bini C, Carnevali E, Casarino L, Di Gaetano C, Fabbri M, Ferri G, Giardina E, Gonzalez A, Matullo G, Nutini AL, Onofri 5th, Piccinini A, Piglionica M, Ponzano E, Previderè C, Resta N, Scarnicci F, Seidita G, Sorçaburu-Cigliero S, Turrina S, Verzeletti A, Kayser M.

Forensic Sci Int Genet. 2018 Apr 5. pii: S1872-4973(18)30195-9. doi: 10.1016/j.fsigen.2018.03.014. [Epub ahead of print] No abstract available.

PMID:
29627344
33.

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.

Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA.

Genome Res. 2018 Apr;28(4):432-447. doi: 10.1101/gr.225128.117. Epub 2018 Mar 22.

34.

Expanding the spectrum of movement disorders in Klinefelter syndrome.

Fabbri M, Zibetti M, Martone T, Lopiano L.

Neurol Sci. 2018 Jul;39(7):1303-1304. doi: 10.1007/s10072-018-3296-3. Epub 2018 Mar 1. No abstract available.

PMID:
29497897
35.

Emerging roles of microRNAs in cancer.

Vannini I, Fanini F, Fabbri M.

Curr Opin Genet Dev. 2018 Feb;48:128-133. doi: 10.1016/j.gde.2018.01.001. Epub 2018 Feb 8. Review.

36.

Corrigendum to "Development of an Italian RM Y-STR haplotype database: Results of the 2013 GEFI collaborative exercise" [Forensic. Sci. Int. Genet. 15 (2015) 56-63].

Robino C, Ralf A, Pasino S, De Marchi MR, Ballantyne KN, Barbaro A, Bini C, Carnevali E, Casarino L, Di Gaetano C, Fabbri M, Ferri G, Giardina E, Gonzalez A, Matullo G, Nutini AL, Onofri V, Piccinini A, Piglionica M, Ponzano E, Previderè C, Resta N, Scarnicci F, Seidita G, Sorçaburu-Cigliero S, Turrina S, Verzeletti A, Kayser M.

Forensic Sci Int Genet. 2018 May;34:e23-e24. doi: 10.1016/j.fsigen.2018.01.008. Epub 2018 Feb 7. No abstract available.

PMID:
29428588
37.

Toxicogenomics applied to in vitro Cell Transformation Assay reveals mechanisms of early response to cadmium.

Callegaro G, Forcella M, Melchioretto P, Frattini A, Gribaldo L, Fusi P, Fabbri M, Urani C.

Toxicol In Vitro. 2018 Apr;48:232-243. doi: 10.1016/j.tiv.2018.01.025. Epub 2018 Jan 31.

PMID:
29408670
38.

The effect of subscapularis tenotomy in athletes operated on for recurrent anterior shoulder dislocation.

Iorio C, Lanzetti RM, Lupariello D, Vadalà A, Fabbri M, Ciompi A, Ferretti A, De Carli A.

Musculoskelet Surg. 2018 Dec;102(3):283-288. doi: 10.1007/s12306-018-0531-2. Epub 2018 Jan 31.

PMID:
29388030
39.

Bone marrow failure may be caused by chromosome anomalies exerting effects on RUNX1T1 gene.

Valli R, Vinti L, Frattini A, Fabbri M, Montalbano G, Olivieri C, Minelli A, Locatelli F, Pasquali F, Maserati E.

Mol Cytogenet. 2018 Jan 11;11:2. doi: 10.1186/s13039-017-0352-2. eCollection 2018.

40.

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Pizzuti L, Sergi D, Sperduti I, Lauro LD, Mazzotta M, Botti C, Izzo F, Marchetti L, Tomao S, Marchetti P, Natoli C, Grassadonia A, Gamucci T, Mentuccia L, Magnolfi E, Vaccaro A, Cassano A, Rossi E, Botticelli A, Sini V, Sarobba MG, Fabbri MA, Moscetti L, Astone A, Michelotti A, De Angelis C, Bertolini I, Angelini F, Ciliberto G, Maugeri-Saccà M, Giordano A, Barba M, Vici P.

Cancer Biol Ther. 2018 Apr 3;19(4):328-334. doi: 10.1080/15384047.2017.1416938. Epub 2018 Feb 16.

41.

Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.

Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M.

Nat Commun. 2018 Jan 8;9(1):160. doi: 10.1038/s41467-017-02485-1.

42.

The Effect of Sequential Tearing of the Anterior Cruciate and Anterolateral Ligament on Anterior Translation and the Pivot-Shift Phenomenon: A Cadaveric Study Using Navigation.

Monaco E, Fabbri M, Mazza D, Daggett M, Redler A, Lanzetti RM, De Carli A, Ferretti A.

Arthroscopy. 2018 Apr;34(4):1009-1014. doi: 10.1016/j.arthro.2017.09.042. Epub 2017 Dec 26.

PMID:
29287952
43.

Health Literacy and Outcomes in Patients With Heart Failure: A Prospective Community Study.

Fabbri M, Yost K, Finney Rutten LJ, Manemann SM, Boyd CM, Jensen D, Weston SA, Jiang R, Roger VL.

Mayo Clin Proc. 2018 Jan;93(1):9-15. doi: 10.1016/j.mayocp.2017.09.018. Epub 2017 Dec 6.

44.

Health self-perception in patient with Crohn's disease: a web survey.

Chiarini M, Di Simone E, Scafuro C, Auddino F, Fabbri M, Delli Poggi A, Catanzaro S, Giannetta N, Di Muzio M.

Clin Ter. 2017 Nov-Dec;168(6):e401-e405. doi: 10.7417/CT.2017.2042.

45.

Biological roles and potential applications of immune cell-derived extracellular vesicles.

Wen C, Seeger RC, Fabbri M, Wang L, Wayne AS, Jong AY.

J Extracell Vesicles. 2017 Nov 22;6(1):1400370. doi: 10.1080/20013078.2017.1400370. eCollection 2017. Review.

46.

The skull roof tracks the brain during the evolution and development of reptiles including birds.

Fabbri M, Mongiardino Koch N, Pritchard AC, Hanson M, Hoffman E, Bever GS, Balanoff AM, Morris ZS, Field DJ, Camacho J, Rowe TB, Norell MA, Smith RM, Abzhanov A, Bhullar BS.

Nat Ecol Evol. 2017 Oct;1(10):1543-1550. doi: 10.1038/s41559-017-0288-2. Epub 2017 Sep 11.

PMID:
29185519
47.

Influence of time-of-day on joint Navon effect.

Fabbri M, Frisoni M, Martoni M, Tonetti L, Natale V.

Cogn Process. 2018 Feb;19(1):27-40. doi: 10.1007/s10339-017-0849-y. Epub 2017 Nov 28.

PMID:
29185170
48.

Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.

Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M.

Nat Commun. 2017 Nov 27;8(1):1801. doi: 10.1038/s41467-017-01562-9. Erratum in: Nat Commun. 2018 Jan 8;9(1):160.

49.

Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.

Samuel P, Mulcahy LA, Furlong F, McCarthy HO, Brooks SA, Fabbri M, Pink RC, Carter DRF.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20170065. doi: 10.1098/rstb.2017.0065.

50.

MicroRNAs and miRceptors: a new mechanism of action for intercellular communication.

Fabbri M.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20160486. doi: 10.1098/rstb.2016.0486. Review.

Supplemental Content

Loading ...
Support Center